Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults

Abroad (travel likely)RecruitingPHASE4

Conditions

Obesity · Weight Reduction · Cardiometabolic Risk Factors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Asian Institute of Medical Sciences, Hyderābād, Sindh, Pakistan
Contact: Study coordinator (Sadik Memon Dr) · sadikmemon@gmail.com · +923009373868
Contact: Study coordinator (Haris Rathore) · aimshyd786@gmail.com · +923138189653
Dr. Fatima Nadeem (Sub-investigator)

Study leads

Dr. Fatima Nadeem
Study Director
Asian Institute Of Medical Sciences
Sadik Memon
Principal Investigator
Asian Institute Of Medical Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

Obesity

Abroad (travel likely)RecruitingPHASE2

Montgomery, United States · Costa Mesa, United States

Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer

Liver Cancer, Adult · MASH - Metabolic Dysfunction-Associated Steatohepatitis · Obesity and Overweight

Abroad (travel likely)Recruiting

La Jolla, United States

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Obesity or Overweight

Abroad (travel likely)RecruitingPHASE3

Anniston, United States · Birmingham, United States

Scaling up Building Healthy Families

Obesity, Child

Abroad (travel likely)Recruiting

Salt Lake City, United States